Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test

NCT03004339 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: SOR007 Ointment 2.0%
DRUG: SOR007 Ointment 1.0%
DRUG: SOR007 Ointment 0.3%
DRUG: SOR007 Ointment 0.15%
DRUG: SOR007 Ointment Placebo
DRUG: Taclonex® Ointment

Sponsor

DFB Soria, LLC

Collaborators

[object Object]
[object Object]